Great Reading For ASTRO!

Are you heading to ASTRO next week? If so, take a look at some incredible articles below (some hot off the press!). Please reach out directly to authors on their work or to CaliberMRI on our phantoms. If you’d like to set up a meeting at ASTRO, please reach out to us directly at info@qmri.com. We look forward to working with you! Warm regards, The CaliberMRI team

Apparent diffusion coefficient benchmarking and inter-scanner variability; preparing for biological image guided adaptive radiotherapy treatments (2025)
148 – REPRODUCIBILITY OF APPARENT DIFFUSION COEFFICIENT ASSESSED ON A 1.5 T MR-LINAC AND A 3T SIEMENS MRI SCANNER FOR PROSTATE PATIENTS (2025)
Technical development and In Silico implementation of SyntheticMR in head and neck adaptive radiation therapy: A prospective R‐IDEAL stage 0/1 technology development report (2025)

Older Articles:

Accurate, repeatable, and geometrically precise diffusion-weighted imaging on a 0.35 T magnetic resonance imaging-guided linear accelerator (2023)

ADC measurements on the Unity MR-linac – a recommendation on behalf of the Elekta Unity MR-linac consortium (2020)

Conformance of a 3T radiotherapy MRI scanner to the QIBA Diffusion Profile (2022)

Feasibility of quantitative relaxometry for prostate target localization and response assessment in magnetic resonance-guided online adaptive stereotactic body radiotherapy (2024)

In Vivo and Phantom Repeatability of Diffusion-Weighted MRI Sequences on 1.5T MRI-Linear Accelerator (MR-Linac) and MR Simulator Devices for Head and Neck Cancers: Results from a Prospective R-IDEAL Stage 2a Evaluation of Tumor and Normal Tissue Apparent Diffusion Coefficients as Quantitative Imaging Biomarkers (2022)

Longitudinal assessment of quality assurance measurements in a 1.5 T MR-linac: Part I—Magnetic resonance imaging (Ergys Subashi, Alex Dresner, Neelam Tyagi) (2022)

Longitudinal assessment of quality assurance measurements in a 1.5 T MR‐linac: Part II—Magnetic resonance imaging (2022)

Prospective evaluation of in vivo and phantom repeatability and reproducibility of diffusion-weighted MRI sequences on 1.5 T MRI-linear accelerator (MR-Linac) and MR simulator devices for head and neck cancers (2023)

Quantifying multi-institutional ADC measurement variability of 1.5 T MR-Linacs: A phantom and in-vivo study (2025)

Quantitative magnetic resonance imaging on hybrid magnetic resonance linear accelerators: Perspective on technical and clinical validation (2020)

Technical Development and In Silico Implementation of SyntheticMR in Head and Neck Adaptive Radiation Therapy: A Prospective R-IDEAL Stage 0/1 Technology Development Report (2024)

The Quality Assurance of a 1.5 T MR-Linac (2024)

Validation of daily 0.35 T diffusion-weighted MRI for MRI-guided glioblastoma radiotherapy (2024)

CaliberMRI User Group Session 2 – June – The variability of Mean ADC Measurements with Simultaneous Multi-slice Imaging in a NIST/QIBA/CaliberMRI Diffusion Phantom

Join us for Session 2: Tuesday, June 24th, 9:00 AM (MDT). To sign up or for login details, please email info[at]qmri.com.
Topic: The variability of Mean ADC Measurements with Simultaneous Multi-slice Imaging in a NIST/QIBA/CaliberMRI Diffusion Phantom
Guest Speakers: Dr. Ryckie Wade, PhD, and Matthew Marzetti, MsC, University of Leeds, United Kingdom

Open Office Hours – Every Tuesday 9-10 a.m. MDT!

Join us for open office hours! Ask questions about your phantom, qCal-MR and meet others advancing quantitative MRI!

2025 User Group Session Calendar!

We are excited to share our 2025 User Group Sessions! Mark your calendars: SESSION 1: Tuesday, April 1st, 9:00 a.m. MDT Topic: Annual Physics Testing with the CaliberMRI Mini Hybrid Phantom. Guest Speaker: Norman P. Sipp, MS DABR, Chief Diagnostic Medical Physicist: Ascension Seton Network-Austin, TX SESSION 2: Tuesday, June 24th, 9:00 a.m. MDT Topic: […]

Federation of American Scientists (FAS) DAY ONE PROGRAM – A Quantitative Imaging Infrastructure to Revolutionize AI-Enabled Precision Medicine

Medical imaging, a non-invasive method to detect and characterize disease, stands at a crossroads. With the explosive growth of artificial intelligence (AI), medical imaging offers extraordinary potential for precision medicine yet lacks adequate quality standards to safely and effectively fulfill the promise of AI. Now is the time to create a quantitative imaging (QI) infrastructure to drive the development of precise, data-driven solutions that enhance patient care, reduce costs, and unlock the full potential of AI in modern medicine.

Read more News

CaliberMRI receives grant for work in Africa and Southeast Asia

Quantitative MRI technology developer CaliberMRI has received a grant from the Bill & Melinda Gates Foundation to help standardize portable MRI imaging for neonatal and pediatric brain development of children in Africa and Southeast Asia.

Read more News

CaliberMRI, Inc. and RSNA’s QIBA Announce First Conformance Certification for Diffusion-Weighted MRI

If this is your first time uploading a Study, your study will be uploaded without being placed inside a folder.

Read more News

CaliberMRI, Inc. Announces Award to Improve Pediatric Brain Imaging at More than 25 Sites Around the World

If this is your first time uploading a Study, your study will be uploaded without being placed inside a folder.

Read more News

CaliberMRI, Inc. Announces Award to Improve Pediatric Brain Imaging at More than 25 Sites Around the World

CaliberMRI, an industry leader in standardization of Magnetic Resonance Imaging (MRI), has been awarded a grant from the Bill & Melinda Gates Foundation to improve repeatability and reproducibility of diagnostic imaging for neonatal and pediatric brain development of children in Africa and Southeast Asia. CaliberMRI supports research into pediatric brain development through standardization and calibration of low […]

Read more News

CaliberMRI Receives State Grant for Biomimetic Quantitative MRI Development

Boulder, Colorado — CaliberMRI is honored to announce it has been awarded an Early-Stage Capital and Retention grant through the Colorado Office of Economic Development and International Trade (OEDIT) Advanced Industries Accelerator program. This funding will help further quantitative Magnetic Resonance Imaging (qMRI) through the development of biomimetic phantoms for use in breast cancer treatment and therapy monitoring. […]

Read more News

Boulder-based CaliberMRI on pace to provide next-generation quality control for MRI scanners worldwide

Nov. 18, 2021 — CaliberMRI, today announced a major milestone in transforming MR imaging into an objective scientific practice using quantitative MRI. Combining its unparalleled NIST-traceable imaging phantom products and automated quality control…

Read more News

CaliberMRI Named a Colorado Companies to Watch Winner

CaliberMRI (CMRI) announced today that it has been named a Colorado Company to Watch, acknowledging the drive, excellence, and influence of CMRI as a growing company in the state. Colorado Companies to Watch honors second-stage companies that develop…

Read more News

Boulder’s CaliberMRI Receives $1.7M Grant from NIH to Advance Monitoring of Breast Cancer Treatment

BOULDER, CO – CaliberMRI, a startup focused on transforming MRI technology, received a $1.72 million grant from the National Cancer Institute, part of the NIH, to mature and test its quantitative MRI (qMRI) technology, the qCal-MR platform…

Read more News